Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
|
Your cart is empty |
|||
Showing 1 - 2 of 2 matches in All Departments
This comprehensive reference provides an in-depth discussion on state-of-the-art regulatory science in bioequivalence. In sixteen chapters, the volume explores a broad range of topics pertaining to bioequivalence, including its origin and principles, statistical considerations, food effect studies, conditions for waivers of bioequivalence studies, Biopharmaceutics Classification Systems, Biopharmaceutics Drug Disposition Classification System, bioequivalence modeling/simulation and best practices in bioanalysis. It also discusses bioequivalence studies with pharmacodynamic and clinical endpoints as well as bioequivalence approaches for highly variable drugs, narrow therapeutic index drugs, liposomes, locally acting gastrointestinal drug products, topical products and nasal and inhalation products. "" "FDA Bioequivalence Standards" is written by FDA regulatory scientists who develop regulatory policies and conduct regulatory assessment of bioequivalence. As such, both practical case studies and fundamental science are highlighted in these chapters. The book is a valuable resource for scientists who work in the pharmaceutical industry, regulatory agencies and academia as well as undergraduate and graduate students looking to expand their knowledge about bioequivalence standards.
This comprehensive reference provides an in-depth discussion on state-of-the-art regulatory science in bioequivalence. In sixteen chapters, the volume explores a broad range of topics pertaining to bioequivalence, including its origin and principles, statistical considerations, food effect studies, conditions for waivers of bioequivalence studies, Biopharmaceutics Classification Systems, Biopharmaceutics Drug Disposition Classification System, bioequivalence modeling/simulation and best practices in bioanalysis. It also discusses bioequivalence studies with pharmacodynamic and clinical endpoints as well as bioequivalence approaches for highly variable drugs, narrow therapeutic index drugs, liposomes, locally acting gastrointestinal drug products, topical products and nasal and inhalation products. FDA Bioequivalence Standards is written by FDA regulatory scientists who develop regulatory policies and conduct regulatory assessment of bioequivalence. As such, both practical case studies and fundamental science are highlighted in these chapters. The book is a valuable resource for scientists who work in the pharmaceutical industry, regulatory agencies and academia as well as undergraduate and graduate students looking to expand their knowledge about bioequivalence standards.
|
You may like...
Carpenter's Exotic Animal Formulary
James W. Carpenter, Craig Harms
Paperback
R1,600
Discovery Miles 16 000
Veg(etari)an Arguments in Culture…
Cristina Hanganu-Bresch, Kristin Kondrlik
Hardcover
R3,541
Discovery Miles 35 410
Animal Biography - Re-framing Animal…
Andre Krebber, Mieke Roscher
Hardcover
R3,710
Discovery Miles 37 100
European Local Pig Breeds - Diversity…
Marjeta Candek-Potokar, Rosa M. Nieto Linan
Hardcover
Fungal Diseases in Animals - From…
Arti Gupta, Nagendra Pratap Singh
Hardcover
R4,953
Discovery Miles 49 530
Neotropical Hard Ticks (Acari: Ixodida…
Alberto A. Guglielmone, Santiago Nava, …
Hardcover
R4,071
Discovery Miles 40 710
Ethnoveterinary Medicine - Present and…
Lyndy J. Mcgaw, Muna Ali Abdalla
Hardcover
R6,691
Discovery Miles 66 910
|